QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 top-3-health-care-stocks-that-may-collapse-in-q2

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum a...

 cyberark-software-to-rally-around-19-here-are-10-top-analyst-forecasts-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 hc-wainwright--co-maintains-buy-on-curis-lowers-price-target-to-26

HC Wainwright & Co. analyst Edward White maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $51 t...

 curis-q4-eps-203-beats-211-estimate-sales-270m-miss-302m-estimate

Curis (NASDAQ:CRIS) reported quarterly losses of $(2.03) per share which beat the analyst consensus estimate of $(2.11) by 3.79...

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 curiss-earnings-a-preview
Curis's Earnings: A Preview
02/07/2024 20:01:47

 why-blackberry-shares-are-trading-lower-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private ...

 curis-announces-initial-combination-study-data-from-its-takeaim-lymphoma-study

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, sm...

 curis-presented-clinical-data-from-the-takeaim-leukemia-study-at-the-2023-ash-conference

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, sm...

 curis-announces-three-presentations-at-ash

PresentationsTakeAim LeukemiaAbstract Title: Preliminary Safety and Efficacy of Emavusertib (CA-4948) in Acute Myeloid Leukemia...

 curis-enters-into-agreement-for-emavusertib--pembrolizumab-combination-study-in-melanoma

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, sm...

 why-genesco-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.

 why-dolby-laboratories-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.

 truist-securities-initiates-coverage-on-curis-with-buy-rating-announces-price-target-of-26

Truist Securities analyst Robyn Karnauskas initiates coverage on Curis (NASDAQ:CRIS) with a Buy rating and announces Price T...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION